PTEN is known to be inactivated by genomic deletion or rearrangements in the early stages of prostate cancer oncogenesis.159,160 Normally, PTEN negatively regulates phosphoinositide 3-kinase (PI3K) activity. Here, PTEN is linked to prostate carcinoma.